Paydirt
LENZ
Ticker

LENZ Therapeutics, Inc.

LENZ · Healthcare · LENZ Therapeutics, Inc. operates as a commercial pharmaceutical company that focuses on the development and commercialization of therapies…

LENZ Therapeutics, Inc. (LENZ), in the Healthcare sector, has 4 disclosed filings on Paydirt over the trailing twelve months from 4 corporate insiders: 2 purchases and 2 sales. Filers took a median of 3 days from execution to disclosure, and the most recent trade was executed Oct 29 and filed Nov 2. The most active filer was James W McCollum with 1 filing. Data as of Nov 8 2026.

Add to watchlist
Filings, ttm
4
2 buys · 2 sells
Traders, ttm
4
4 insiders
Volume, ttmiDollar value disclosed in the window
$9.4M
estimated for Congress, as filed for insiders
Median delay
3d
execution to disclosure
Last traded
Oct 29
Filed Nov 2
ADViAverage daily dollar volume
$2.6M
market data
Share price · 12M
$3.50 (-84.9%)
$31.94$17.48$3.01Nov 10 2025May 12Nov 6

Adjusted for splits and dividends.

Volume by month
$20.3M$10.1M$0Dec 2024Jun 2025Dec 2025Jun 2026Jun 2025 · sells $20.3MJul 2025 · sells $12.6MNov 2025 · buys $239KNov 2025 · sells $261KMar 2026 · buys $251KNov 2026 · sells $9.1M
Buys $491K Sells $42.3M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed · past 24 months
VL Versant Vantage II GP-GP, LLC 10% owner 3 filings · 0 buys, 3 sales VP Versant Venture Capital VI, L.P. 10% owner 2 filings · 0 buys, 2 sales JM James W McCollum Director 1 filing · 1 buy, 0 sales SO Shawn Olsson Chief Commercial Officer 1 filing · 0 buys, 1 sale RP Ra Capital Management, L.P. Director 1 filing · 0 buys, 1 sale ES Evert B. Schimmelpennink President, CEO and Secretary 1 filing · 1 buy, 0 sales VP Versant Ventures VI GP, L.P. 10% owner 1 filing · 0 buys, 1 sale VP Versant Ventures VII GP, L.P. 10% owner 1 filing · 0 buys, 1 sale
All 9 filers VL Versant Ventures VII GP-GP, LLC 10% owner 1 filing · 0 buys, 1 sale
Recent filings
Ra Capital Management, L.P.SALE 10% owner $9.1M
2,718,684 sh across 3 lots
Exec Oct 29
Filed Nov 2 · 5:44 PM ET Evert B. SchimmelpenninkPURCHASE President, CEO and Secretary $251K
28,089 sh × $8.95
Exec Mar 27
Filed Mar 30 · 8:46 AM ET Shawn OlssonSALE Chief Commercial Officer $261K
10,000 sh across 2 lots
Exec Nov 17 2025
Filed Nov 19 2025 · 5:30 PM ET James W McCollumPURCHASE Director $239K
10,500 sh × $22.79
Exec Nov 7 2025
Filed Nov 10 2025 · 4:13 PM ET Versant Vantage II GP-GP, LLCSALE 10% owner –
224,674 sh across 4 lots · price not plausible
Exec Sep 30 2025
Filed Oct 2 2025 · 5:30 PM ET Versant Venture Capital VI, L.P.SALE 10% owner –
134,904 sh across 4 lots · price not plausible
Exec Sep 18 2025
Filed Sep 22 2025 · 5:30 PM ET Versant Ventures VII GP, L.P.SALE 10% owner –
183,180 sh across 9 lots · price not plausible
Exec Aug 22 2025
Filed Aug 26 2025 · 5:30 PM ET Versant Venture Capital VI, L.P.SALE 10% owner –
260,713 sh across 4 lots · price not plausible
Exec Aug 15 2025
Filed Aug 19 2025 · 5:30 PM ET Versant Ventures VII GP-GP, LLCSALE 10% owner $6.5M
191,376 sh × $34.00
Exec Jul 10 2025
Filed Jul 14 2025 · 5:30 PM ET Versant Vantage II GP-GP, LLCSALE 10% owner $6.1M
200,000 sh × $30.47
Exec Jun 27 2025
Filed Jul 1 2025 · 5:30 PM ET Versant Ventures VI GP, L.P.SALE 10% owner $10.1M
334,801 sh across 3 lots
Exec Jun 18 2025
Filed Jun 20 2025 · 5:30 PM ET Versant Vantage II GP-GP, LLCSALE 10% owner $10.2M
350,000 sh × $29.00
Exec Jun 10 2025
Filed Jun 12 2025 · 5:30 PM ET